Celox

Celox Medical develops patented medical technologies for critical wound care, specializing in advanced hemostatic and wound management solutions. The company creates evidence-based agents that control bleeding and support healing for various wounds. Its portfolio features innovative dressings for rapid application and proven efficacy in urgent scenarios.

Founded in 1999 by Craig Hardy as Medtrade Products Ltd., the company originated from a critical need for effective hemorrhage and advanced wound care. Hardy established the firm to improve patient outcomes via novel medical technologies. It later rebranded as Celox Medical, reflecting its specialized focus on patented, lifesaving interventions.

Celox Medical’s products serve military, tactical, EMS, hospitals, and long-term care facilities. They provide professionals with reliable, rapid solutions for managing severe bleeding and complex wounds. The company’s mission is to save and enhance lives through continuous innovation in bleeding control and wound healing for global impact.